Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

March 5, 2021

Study Completion Date

March 5, 2021

Conditions

Healthy Participants

Interventions

DRUG

Caffeine

100milligram (mg) tablet taken orally in period 1 and period 2

OTHER

Ritlecitinib

200 milligrams (mg) taken orally once a day(QD) for 8 days

Trial Locations (1)

New Haven Clinical Research Unit, New Haven